Vaginal Yeast Infection - Metairie LA (Clinical Trial # 20049)

This study is not currently recruiting Study Participants on If you would like to find active studies please search for clinical trials.
Browse Studies

City: Metairie
State: LA
Zip Code: 70006
Study summary: A phase 1b/2a, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety, tolerability, immunogenicity and efficacy in preventing Vulvovaginal Candidiasis in subjects with recurrent Vulvovaginal Candidiasis following administration of a single dose of ndv-3a vaccine, ndv-3 vaccine, or placebo” (the "protocol").
Qualified participants must: • Be 18-50 years of age
• Have a current episode of Yeast
• Have responded to 3 doses oral fluconazole
• Have normal pap smear and be in good health
Participants may receive: Fluconazole and a vaccine injection against Vaginal Candida Albicans and a $100 stipend for each visit to compensate for time and travel.
Clinic Profile: View Clinic Profile

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.